Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation

The +16 exon 10 splice mutation of the tau gene (microtubule‐associated protein tau, MAPT) has been reported in numerous families with frontotemporal dementia (FTD). To date, the majority of these families are from England and Wales in the UK, although families with this mutation have been reported from Australia and the USA. Our own analysis has identified eight families with the +16 MAPT splice mutation from around the Manchester and North Wales areas of the UK. Given the proximity of the UK families to one another it is likely that they are related and represent a single extended pedigree. In order to investigate this possibility, and the possibility that the families with this mutation from London, the USA, and Australia are related, we genotyped 11 microsatellite markers around the tau locus. In most cases (20/25, 80%), a common haplotype, approximately 3 cM in size, was identified. In the remaining cases, this haplotype appears to have been varyingly reduced in size by recombination. We demonstrate that the +16 mutation is on the H1 tau haplotype and that H1 specific polymorphisms are also shared by these families. These data provide evidence that the MAPT +16 splice mutation cases from around the world analyzed in this study are indeed related and represent a single pedigree that probably originated in the North Wales area of the UK. Furthermore, this single large pedigree may be of use in the identification of disease modifying loci in FTD. © 2003 Wiley‐Liss, Inc.

[1]  R. Uitti,et al.  Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation , 2003, Neurology.

[2]  P. Lantos,et al.  Neuropathologic variation in frontotemporal dementia due to the intronic tau 10+16 mutation , 2002, Neurology.

[3]  Nick C Fox,et al.  Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation , 2002, Neurology.

[4]  J. Hardy,et al.  Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. , 2002, Brain : a journal of neurology.

[5]  T. Iwatsubo,et al.  Late‐onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation , 2002, Annals of neurology.

[6]  G. Schellenberg,et al.  Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. , 2001, Archives of neurology.

[7]  M. Hutton,et al.  Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.

[8]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[9]  A. Grover,et al.  5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10* , 1999, The Journal of Biological Chemistry.

[10]  D. Dickson,et al.  Tau gene mutation in familial progressive subcortical gliosis , 1999, Nature Medicine.

[11]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[12]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[14]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[15]  N L Foster,et al.  Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.

[16]  L. Thal,et al.  Genetic evidence for the involvement of τ in progressive supranuclear palsy , 1997, Annals of neurology.

[17]  F. Dark A Family with Autosomal Dominant, Non-Alzheimer's Presenile Dementia , 1997, The Australian and New Zealand journal of psychiatry.

[18]  K. Wilhelmsen,et al.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. , 1994, American journal of human genetics.

[19]  D. Neary,et al.  Dementia of frontal lobe type: neuropathology and immunohistochemistry. , 1993, Journal of neurology, neurosurgery, and psychiatry.